These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18458051)

  • 21. [The high-sensitivity C-reactive protein level one month after bare-metal coronary stenting may predict late adverse events].
    Fournier JA; Delgado-Pecellín C; Cayuela A; Cabezón S; Mendoza MD
    Rev Esp Cardiol; 2008 Mar; 61(3):313-6. PubMed ID: 18361906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.
    Sierros V; Fleming R; Cascioli M; Brady T
    Chron Respir Dis; 2009; 6(3):149-55. PubMed ID: 19643829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease.
    Han SH; Choi HY; Kim DK; Moon SJ; Lee JE; Yoo TH; Kim BS; Kang SW; Choi KH; Lee HY; Han DS
    Am J Nephrol; 2009; 29(2):129-35. PubMed ID: 18719346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
    Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
    Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study.
    Dieplinger B; Haltmayer M; Poelz W; Mueller T
    Clin Chim Acta; 2009 Oct; 408(1-2):87-91. PubMed ID: 19646980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence.
    Merino J; Planas A; De Moner A; Gasol A; Contreras C; Marrugat J; Vidal-Barraquer F; Clarà A
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):71-6. PubMed ID: 18396072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein is an essential aspect of cardiovascular risk factor stratification.
    Yeh ET
    Can J Cardiol; 2004 Aug; 20 Suppl B():93B-96B. PubMed ID: 15309212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive assessment of cardiovascular risk: from Framingham to the future.
    Vogel RA; Benitez RM
    Rev Cardiovasc Med; 2000; 1(1):34-42. PubMed ID: 12457150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of hypotensive blood pressure response during single-stage exercise test on long-term outcome in patients with known or suspected peripheral arterial disease.
    de Liefde II; Hoeks SE; van Gestel YR; Klein J; Verhagen HJ; van Domburg RT; Poldermans D
    Coron Artery Dis; 2008 Dec; 19(8):603-7. PubMed ID: 19005295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative cardiac risk index predicts long-term mortality and health status.
    Hoeks SE; op Reimer WJ; van Gestel YR; Smolderen KG; Verhagen H; van Domburg RT; van Urk H; Poldermans D
    Am J Med; 2009 Jun; 122(6):559-65. PubMed ID: 19376487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.
    Speidl WS; Exner M; Amighi J; Kastl SP; Zorn G; Maurer G; Wagner O; Huber K; Minar E; Wojta J; Schillinger M
    Eur Heart J; 2005 Nov; 26(21):2294-9. PubMed ID: 15917276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
    Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
    Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.